Company News

Stay up to date on the exciting events that happen with Tower MSA and our industry.

FDA Approves Generic Release of Abilify

Posted on May 1, 2015 by Rita Wilson

The U.S. Food and Drug Administration (FDA) approved the first AB-rated generics to Bristol-Myers Squibb and Otsuka’s Abilify® (aripiprazole) tablets, an atypical antipsychotic drug commonly used for treating schizophrenia and bipolar disorder. The agency approved generics from Alembic Pharmaceuticals, Hetero…

Read more